Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3H2101
Fri, 17.12.2021
aap Implantate AG
aap Implantate AG ("aap" or the "Company") announces that the Supervisory Board resolved to extend the contracts of Chairman of the Management Board (CEO) Rubino Di Girolamo and the two Management Board members Marek Hahn (CFO) and Agnieszka Mierzejewska (COO) by two years until the end of the financial year 2023.
"Over the past 2.5 years, under [ … ]
Fri, 10.12.2021
aap Implantate AG
aap Implantate AG ("aap" or the "Company") announces that the human clinical study for its innovative antibacterial silver coating technology started yesterday. The University Hospital in Regensburg is the first trial center which was equipped with the study materials and trained to perform surgeries with the Company's silver coated implants.
aa [ … ]
Thu, 25.11.2021
aap Implantate AG
The convertible bond 2020/2023 of aap Implantate AG ("aap" or the "Company") is divided into partial bearer bonds ("bonds") with a nominal value of EUR 1.75 each, ranking pari passu among themselves. In accordance to the terms and conditions of the bonds, each bondholder is entitled to convert each bond initially at its nominal value into ordinary [ … ]
Fri, 12.11.2021
aap Implantate AG
- Sales increased 15% (Q3) to EUR 3.0 million and 29% (9M) to EUR 8.9 million (CER[1]: 18% (Q3) and 39% (9M))
- Continued positive EBITDA in Q3 and 9M; >+100% increase (Q3) to KEUR 20 and >+100% (9M) to EUR 0.1 million
- Operating cash flow balanced for first time in Q3; +87% improvement to EUR -0.4 million (9M); still clear trend toward [ … ]
Thu, 21.10.2021
aap Implantate AG
aap Implantate AG ("aap" or the "Company") has successfully completed the capital increase with subscription rights resolved on 27 September 2021. The order book both for placed oversubscriptions and the private placement was significantly oversubscribed, so that demand could not be fully met. In total, all 1,500,000 aap shares offered in the subsc [ … ]
Wed, 20.10.2021
aap Implantate AG
The Management Board of aap Implantate AG ("aap" or the "Company") announces that, following completion of the private placement as part of the capital increase with subscription rights, demand for new shares in aap was significantly higher than the total volume of the capital measure with 1.5 million offered new shares. The capital increase is the [ … ]
Thu, 14.10.2021
aap Implantate AG
aap Implantate AG ("aap" or the "Company") announces a change in the composition of its Supervisory Board. As part of aap's further transformation, Mr. Marc Langner (45) will strengthen the Company's supervisory body with effect from 1 November 2021. Marc Langner is the founder and CEO of a listed investment company specializing in venture capital [ … ]
Mon, 04.10.2021
aap Implantate AG
With the turnaround following the successful restructuring of the last two years and the significant sales growth in the first half of 2021, aap Implantate AG ("aap" or the "Company") has laid the foundation for the capital increase starting today. The successes of the extensive restructuring are particularly reflected in a significant improvement [ … ]
Mon, 27.09.2021
aap Implantate AG
The Management Board of aap Implantate AG ("aap" or the "Company") resolved on 27 September 2021 with the approval of the Supervisory Board of the same day on a capital increase against cash contributions out of the authorized capital 2019/I with subscription and oversubscription rights of the shareholders of the Company. aap's share capital shall [ … ]
Tue, 21.09.2021
aap Implantate AG
aap Implantate AG ("aap" or the "Company") announces that three implants coated with the Company's innovative antibacterial silver technology have already been implanted in patients. With its antibacterial silver coating technology, aap addresses one of the greatest and as yet inadequately solved challenges in traumatology: the reduction of surgica [ … ]